In the present study, we confirmed the upregulation of hepatic DPP4 expression both in vivo (in the AMLN diet-induced NASH mouse model) and in vitro (in palmitate-stimulated HepG2 cells). Here, DPP4 is linked to metabolic dysfunction-associated steatohepatitis.